Mangoceuticals gets Nasdaq extension to regain $1 minimum bid price compliance by Feb. 1, 2027

Reuters2026/08/04 20:37

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Mangoceuticals received a 180-day Nasdaq extension to regain compliance with the $1 minimum bid price rule.
The deadline to meet the requirement is Feb. 1, 2027, with compliance defined as at least 10 consecutive business days at $1 or higher.
The company signaled it may use a reverse stock split to cure the deficiency within the extension period.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mangoceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-035993), on August 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Mangoceuticals gets Nasdaq extension to regain $1 minimum bid price compliance by Feb. 1, 2027

You may also like

Crypto prices